Cullen/Frost Bankers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,882
Closed -$2.27M 1119
2019
Q3
$2.27M Sell
22,882
-4,154
-15% -$395K 0.07% 201
2019
Q2
$2.5M Sell
27,036
-149,924
-85% -$14.2M 0.08% 186
2019
Q1
$16.6M Sell
176,960
-2,950
-2% -$258K 0.51% 64
2018
Q4
$11.5M Sell
179,910
-10,217
-5% -$754K 0.43% 75
2018
Q3
$17M Sell
190,127
-9,748
-5% -$861K 0.53% 63
2018
Q2
$15.9M Sell
199,875
-21,014
-10% -$1.74M 0.49% 71
2018
Q1
$19.7M Buy
220,889
+36,545
+20% +$3.51M 0.58% 63
2017
Q4
$19.2M Sell
184,344
-4,324
-2% -$488K 0.61% 57
2017
Q3
$27.5M Buy
188,668
+2,165
+1% +$295K 0.9% 25
2017
Q2
$24.2M Sell
186,503
-1,346
-0.7% -$165K 0.81% 33
2017
Q1
$23.4M Sell
187,849
-4,071
-2% -$487K 0.8% 35
2016
Q4
$22.2M Sell
191,920
-602
-0.3% -$67K 0.76% 43
2016
Q3
$20.1M Buy
192,522
+24,927
+15% +$2.7M 0.72% 46
2016
Q2
$16.5M Buy
167,595
+385
+0.2% +$39.8K 0.61% 64
2016
Q1
$16.7M Buy
167,210
+8,644
+5% +$890K 0.63% 65
2015
Q4
$19M Buy
158,566
+1,280
+0.8% +$148K 0.72% 49
2015
Q3
$17M Buy
157,286
+3,551
+2% +$441K 0.68% 50
2015
Q2
$17.8M Buy
153,735
+20,320
+15% +$2.32M 0.66% 50
2015
Q1
$15.4M Buy
133,415
+3,994
+3% +$477K 0.58% 60
2014
Q4
$14.5M Buy
129,421
+281
+0.2% +$29.6K 0.56% 57
2014
Q3
$12.2M Buy
129,140
+2,217
+2% +$200K 0.5% 67
2014
Q2
$10.9M Buy
126,923
+301
+0.2% +$22.9K 0.44% 79
2014
Q1
$8.84M Sell
126,622
-40,828
-24% -$3.23M 0.38% 92
2013
Q4
$14.1M Buy
167,450
+4,074
+2% +$322K 0.63% 48
2013
Q3
$12.6M Buy
163,376
+964
+0.6% +$67.6K 0.62% 50
2013
Q2
$9.5M Buy
+162,412
New +$9.77M 0.5% 64

Other funds holding CELG

Cullen/Frost Bankers's CELG Position: Q4 2019 in Review

Cullen/Frost Bankers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,882 shares — an estimated $2.27M sold.

Cullen/Frost Bankers first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $27.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cullen/Frost Bankers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cullen/Frost Bankers sold 22,882 Celgene Corp shares in Q4 2019, an estimated $2.27M.
  • Cullen/Frost Bankers first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Cullen/Frost Bankers's Celgene Corp position peaked at $27.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cullen/Frost Bankers's 13F filing for Q4 2019, filed 6 Feb 2020.